Katie Peng
Director/Board Member bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 476 412 $ am 31.03.2024
Profil
Katie Peng is an Independent Director at Scholar Rock Holding Corp., a Director at California Life Sciences Association, and an Independent Director at Adicet Bio, Inc. She was previously a Senior Vice President & Head-OMNI Business Unit at Genentech, Inc. She received an undergraduate degree from the University of California, Berkeley and an MBA from Kelley School of Business.
Additionally, she is currently the Chief Commercial Officer at Denali Therapeutics, Inc.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
09.04.2024 | 26 825 ( 0,03% ) | 476 412 $ | 31.03.2024 | |
ADICET BIO INC
-.--% | 14.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Katie Peng
Unternehmen | Position | Beginn |
---|---|---|
DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 27.09.2021 |
ADICET BIO, INC. | Director/Board Member | 10.07.2023 |
SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 15.02.2024 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | - |
Ehemalige bekannte Positionen von Katie Peng
Unternehmen | Position | Ende |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Katie Peng
University of California, Berkeley | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
DENALI THERAPEUTICS INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
ADICET BIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |